CGENCompugen Ltd.

$202M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M

Gross Profit

$14M79.0% margin

Operating Income

$4M26.2% margin

Net Income

$1M7.4% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

+155.6%

Balance Sheet

Total Assets

$124M

Total Liabilities

$63M

Stockholders' Equity

$60M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$0	—
Gross Profit	$14M	$0	—
Operating Income	$4M	-$11M	+142.3%
Net Income	$1M	-$10M	+113.0%

CGEN Q3 2024 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena